Connect with us

TechCrunch

FindAir is a smart inhaler

FindAir is digitizing asthma therapy with smart inhaler technology. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech…

Published

on

FindAir is digitizing asthma therapy with smart inhaler technology.

The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education.

TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Continue Reading
Advertisement
9 Comments

9 Comments

  1. Abhishek Rao Chimbili

    October 27, 2019 at 4:51 pm

    That is the most useless thing I’ve ever seen.

  2. Brandon S.

    October 27, 2019 at 4:52 pm

    You are supposed to use a spacer. The inhaler alone is not good. Not to mention there are some inhalers that already track the number of uses. This is pointless.

  3. Greg Nulik

    October 27, 2019 at 7:21 pm

    Hope the sensor supports a full dosage.

  4. polyannamoonbeam

    October 27, 2019 at 10:39 pm

    Not enough info …sensor tells you what your trigger was…? How? Blood prick analysis? Heartrate? Allergen analysis? Doctors are now instructed to ration patients to one Ventolin a month, two if you argue at length. There is no science to back up patients self diagnosed need for more, doctors differ on what is sufficient, how to measure severity and are often punitive/ biased against smokers. Many patients become resistant to their Ventolyn due to misuse, long term use.. tracking usage doesnt tell you whether patient needed to use more or less puffs for each event or just misused due to poor technique….severe attacks are not managed by Ventolin. Steroids,adrenalin, intravenous meds, full mask vaporised meds- we use all in winter for son.

  5. Pinitrius

    October 27, 2019 at 11:34 pm

    Being an allergist I was interested to see what this was about… But no! It gives some information about patient adherence to the treatment but as with many products/service it is trying to force a subscription down patients throat without providing real long term value! And the product itself is rendered useless after 12 months due to the non-removable battery!

    To me it is just a gimmick the way they chose to make it and charge for it! Sorry…

  6. TechPimp

    October 28, 2019 at 1:51 am

    I didn’t understand what the heck it does?

  7. Gezaei Teklay

    October 28, 2019 at 2:09 am

    I hope it is helpful for asthma

  8. Arthur

    October 28, 2019 at 9:12 am

    So it counts how many times you use an inhaler a day and displays it on an app?

  9. takeonparis

    October 29, 2019 at 12:15 am

    This is the dumbest interview I’ve ever seen. He doesn’t even bother to ask: “So what does your product DO?” Like what in the actual hell…

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

Eclipse Ventures Co-Founder Lior Susan’s Insights Into a $1.3B Bet on Physical AI | StrictlyVC

Fresh off raising a $1.3 billion fund, Eclipse Ventures is doubling down on what it calls physical AI. In this StrictlyVC interview from our 2026 event in San Francisco, co-founder and managing partner Lior Susan discusses robotics, manufacturing, autonomous systems, and what it takes to build enduring companies where AI meets the physical world. Plus,…

Published

on

Fresh off raising a $1.3 billion fund, Eclipse Ventures is doubling down on what it calls physical AI. In this StrictlyVC interview from our 2026 event in San Francisco, co-founder and managing partner Lior Susan discusses robotics, manufacturing, autonomous systems, and what it takes to build enduring companies where AI meets the physical world. Plus, you can get a peek into Susan’s perspective about the SpaceX IPO.

Subscribe for more on YouTube:

Follow TechCrunch on Instagram:
TikTok:
X: tcrn.ch/x
Threads:
Facebook:
Bluesky:
Mastodon:
Read more:

Continue Reading

Science & Technology

The OpenAI vs. Elon Musk Trial Is Getting Messy Fast | Equity Podcast

Elon vs. Altman is just getting started, and Musk’s own tweets are already working against him in court. Shareholders, take note 👀 Catch the full breakdown on the latest Equity podcast episode:

Published

on

Elon vs. Altman is just getting started, and Musk’s own tweets are already working against him in court. Shareholders, take note 👀

Catch the full breakdown on the latest Equity podcast episode:

Continue Reading

Science & Technology

Campbell Brown on Going From Anchor to Facebook to Founding Forum AI | StrictlyVC

Campbell Brown has seen the information ecosystem from every angle — as a journalist, as Meta’s former head of news, and now as founder and CEO of Forum AI. In this StrictlyVC interview from our 2026 event in San Francisco, she discusses trustworthy AI, misinformation at scale, and what it takes to build reliable information…

Published

on

Campbell Brown has seen the information ecosystem from every angle — as a journalist, as Meta’s former head of news, and now as founder and CEO of Forum AI. In this StrictlyVC interview from our 2026 event in San Francisco, she discusses trustworthy AI, misinformation at scale, and what it takes to build reliable information systems in the age of AI.

Subscribe for more on YouTube:

Follow TechCrunch on Instagram:
TikTok:
X: tcrn.ch/x
Threads:
Facebook:
Bluesky:
Mastodon:
Read more:

Continue Reading

Trending